• Users Online: 508
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2020  |  Volume : 4  |  Issue : 2  |  Page : 73-78

Human T lymphotropic virus antibodies seroprevalence among healthy blood donors and high risk groups at Riyadh regional laboratory in Riyadh, Saudi Arabia


1 Department of Microbiology and Virology, Riyadh Regional Laboratory, Riyadh, KSA
2 Department of Microbiology and Virology, Riyadh Regional Blood Bank, Riyadh Regional Laboratory, Riyadh, KSA

Correspondence Address:
Fadel Hassan Al-Hababi
Department of Microbiology and Virology, Riyadh Regional Laboratory, King Saud Medical Complex, P.O. Box 61734, Riyadh 11757
KSA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/sccj.sccj_13_20

Rights and Permissions

Aims: Transmission of human T lymphotropic viruses (HTLV) testing performed as routine pretransfusion screening. In Riyadh city the prevalence of HTLV1/2 among healthy volunteers in Riyadh city more than two decades. In addition, no information available related to the HTLV1/2 infections in HIV/AIDS patients. This study first aims to determine the prevalence of HTLV1/2 infections among healthy volunteers in Riyadh city. Second, as HTLV1/2 transmission similar as HIV routes, we assess rates of HTLV1/2 coinfection among patients infected with HIV. Materials and Methods: A retrospective study depends on the data obtained from Riyadh Regional Laboratory (RRL) for 3 years, 2017–2019. The samples enrolled in study consist of 114638 healthy blood donors and 243 patient samples referred to RRL virology samples. In addition, 474 HIV-infected patients were included. All serum samples tested to detect infection with HTLV1/2 by commercial CMIA or enzyme-linked immunosorbent assay kits and any positive results confirmed and differentiated by western blot. Results: Among of 114638 blood donations were tested, only two confirmed HTLV1 positive found from two (0.002%) donors, one of them is Saudi female and the second donor was expatriates. None was positive for anti-HTLV2. The overall HTLV1 prevalence was 1.7/100,000 donations during the 3 years tested. In addition, none of the referred sample was positive for anti-HTLV1/2. In addition, a large number of HIV-positive individual population enrolled none tested positive for HTLV1/2. Conclusions: HTLV seroprevalence is very low among healthy blood donors population in Riyadh city, which reflects the situation in the general population. However, screening for HTLV1/2 blood donors for the first donation from endemic countries donors would keep safe blood donation in Saudi Arabia.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed267    
    Printed18    
    Emailed0    
    PDF Downloaded36    
    Comments [Add]    

Recommend this journal